Figure 7

(A) MTT assay was performed in PR cells treated with Skp2 siRNA. *P<0.05 compared with control siRNA. (B) A proposed model for Skp2 in PR EMT-type cells. Abbreviations: BC=breast cancer; CS=control siRNA; EMT=epithelial-to-mesenchymal transition; PR=paclitaxel-resistant; SS=Skp2 siRNA.